Challenges in tacrolimus dosing in mutant CYP3A5*3/3*renal transplant patients leading to over immunosuppression and persistent post-transplant covid viremia

被引：0
|
作者：
Chauhan, Sanjeev [1 ]
Sharma, Ashish [1 ]
Kenwar, Deepesh Benjamin [1 ]
Singh, Sarbpreet [1 ]
Patil, Shiva Kumar [1 ]
Patniak, Samita [2 ]
Karthik, Nasika Venkata Kanaka Naga [1 ]
Panjathia, Arun [1 ]
Bhushan, Bharat [1 ]
Reddy, Perugu Sai Praneeth [1 ]
Gysley, Belmin Winston [1 ]
机构：
[1] Post Grad Inst Med Educ & Res, Ranal Transplant Surg, Chandigarh, India
[2] Post Grad Inst Med Educ & Res, Clin Pharmacol, Chandigarh, India
来源：
TRANSPLANTATION | 2024年 / 108卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P.075
引用
收藏
页码：482 / 482
页数：1
相关论文
共 50 条
  • [21] Association between CYP3A5 Gene Polymorphism and Post-Transplant Acute Immune Rejection in Renal Transplant Recipients Receiving Tacrolimus Therapy: A Correlation Study
    Jia, Jia
    Zhao, Rong
    Danzheng, Jiancuo
    ARCHIVOS ESPANOLES DE UROLOGIA, 2024, 77 (06): : 688 - 694
  • [22] Frequencies of the CYP3A5*3 variant in renal transplant patients in Northern Portugal
    Lima, Carla
    Peixoto, Maria
    Dias, Manuel
    Alves, Helena
    TISSUE ANTIGENS, 2010, 75 (05): : 589 - 590
  • [23] Population Pharmacokinetic of Tacrolimus in Tunisian Renal Transplant Patients: Influence of CYP34A and CYP3A5 Polymorphisms
    Ben-Fredj, N.
    Hannachi, I.
    Chadli, Z.
    Kerkeni, E.
    Ben-Romadhane, H.
    Ben-Fadhel, N.
    Hammouda, M.
    Boughattas, N. A.
    Chaabane, A.
    Aouam, K.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 : 74 - 74
  • [24] Switching Immunosuppression From Cyclosporine to Tacrolimus in Kidney Transplant Recipients Based on CYP3A5 Genotyping
    Wang, Xuebin
    Yang, Yunyun
    Liu, Zhengyue
    Xiao, Chengwu
    Gao, Lihong
    Zhang, Wenjing
    Zhang, Wenwen
    Wang, Zhuo
    THERAPEUTIC DRUG MONITORING, 2019, 41 (01) : 97 - 101
  • [25] Influence of combined CYP3A4 and CYP3A5 single-nucleotide polymorphisms on tacrolimus exposure in kidney transplant recipients: a study according to the post-transplant phase
    Aouam, Karim
    Kolsi, Abdessalem
    Kerkeni, Emna
    Ben Fredj, Nadia
    Chaabane, Amel
    Monastiri, Kamel
    Boughattas, Naceur
    PHARMACOGENOMICS, 2015, 16 (18) : 2045 - 2054
  • [26] Impact of CYP3A5 Genotype on Tacrolimus Dosing Requirements and Trough Concentrations in Cardiac Transplant Recipients
    Wu, Yanting
    Eadon, Michael T.
    Schenkelberg, Laurie
    Rao, Roopa A.
    Skaar, Todd C.
    Tillman, Emma M.
    Shugg, Tyler A.
    PHARMACOGENETICS AND GENOMICS, 2025, 35 (01): : 20 - 20
  • [27] ASSOCIATION BETWEEN CYP3A5*3 AND PPARA GENE VARIANTS ON TACROLIMUS CONCENTRATIONS IN RENAL TRANSPLANT RECIPIENTS
    Lunde, Ingrid
    Midtvedt, Karsten
    Mohebi, Beata
    Dahl, Miriam
    Bergan, Stein
    Asberg, Anders
    Christensen, Hege
    Bremer, Sara
    TRANSPLANT INTERNATIONAL, 2013, 26 : 252 - 252
  • [28] INFLUENCE OF CYP3A5 GENOTYPE ON THE PHARMACOKINETIC PROFILE OF TACROLIMUS IN PAEDIATRIC TRANSPLANT PATIENTS
    McLean, K.
    Fung, A.
    Gijsen, V.
    Nalli, N.
    Safi, M.
    Daljevic, T.
    Ogaki, C.
    Mital, S.
    CANADIAN JOURNAL OF CARDIOLOGY, 2012, 28 (05) : S291 - S291
  • [29] Influence of CYP3A5 Polymorphisms On Tacrolimus Pharmacokinetics and Renal Function in Renal Transplant Recipients.
    Salvador-Garrido, P.
    Outeda-Macias, M.
    Pedreira-Vazquez, I.
    Elberdin-Pazos, L.
    Fernandez-Rivera, C.
    Alonso-Hernandez, A.
    Martin-Herranz, I.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 618 - 618
  • [30] Influence of CYP3A5 Polymorphisms On Tacrolimus Pharmacokinetics and Renal Function in Renal Transplant Recipients.
    Salvador-Garrido, P.
    Outeda-Macias, M.
    Pedreira-Vazquez, I.
    Elberdin-Pazos, L.
    Fernandez-Rivera, C.
    Alonso-Hernandez, A.
    Martin-Herranz, I.
    TRANSPLANTATION, 2014, 98 : 618 - 618
12345